P53 inhibitor pifithrin-α p-nitro (PFT) abrogated the HFD-induced overexpressing of miR-34a and activate the SIRT/PGC1α/PPARα axis, which diminished hepatic TG deposition and ameliorated the liver steatosis [96]. The gene discussed is PPARA; the disease is fatty liver disease.